Sotrovimab (Gen1)
VIR-7831-5006
Phase 2 mab completed
Quick answer
Sotrovimab (Gen1) for Covid19 is a Phase 2 program (mab) at Vir Biotechnology with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vir Biotechnology
- Indication
- Covid19
- Phase
- Phase 2
- Modality
- mab
- Status
- completed